AIM ImmunoTech (AMEX: AIM)
|Date||Analyst Firm||Analyst Name||Action||Rating||Action Price||Prior Price||Target|
You can purchase shares of AIM ImmunoTech (AMEX: AIM) through any online brokerage.
There are no as such competitors for AIM ImmunoTech.
The latest price target for AIM ImmunoTech (AMEX: AIM) was reported by Maxim Group on Thursday, October 10, 2019. The analyst firm set a price target for 0.00 expecting AIM to fall to within 12 months (a possible -100.00% downside). 0 analyst firms have reported ratings in the last year.
The stock price for AIM ImmunoTech (AMEX: AIM) is $0.8599 last updated June 24, 2022, 7:59 PM UTC.
There are no upcoming dividends for AIM ImmunoTech.
AIM ImmunoTech’s Q2 earnings are confirmed for Monday, August 15, 2022.
There is no upcoming split for AIM ImmunoTech.
AIM ImmunoTech is in the Healthcare sector and Biotechnology industry. They are listed on the AMEX.